147 related articles for article (PubMed ID: 35993296)
21. Effect of Lifestyle Intervention on Cardiometabolic Risk Factors in Overweight and Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
Khatlani K; Njike V; Costales VC
Metab Syndr Relat Disord; 2019 Dec; 17(10):473-485. PubMed ID: 31513475
[TBL] [Abstract][Full Text] [Related]
22. Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility.
Panidis D; Tziomalos K; Papadakis E; Vosnakis C; Chatzis P; Katsikis I
Endocrine; 2013 Dec; 44(3):583-90. PubMed ID: 23625194
[TBL] [Abstract][Full Text] [Related]
23. The role of obesity in the development of polycystic ovary syndrome.
Motta AB
Curr Pharm Des; 2012; 18(17):2482-91. PubMed ID: 22376149
[TBL] [Abstract][Full Text] [Related]
24. Effect of d-chiro-inositol and alpha-lipoic acid combination on COH outcomes in overweight/obese PCOS women.
Artini PG; Obino MER; Micelli E; Malacarne E; Vacca C; Papini F; Cela V
Gynecol Endocrinol; 2020 Sep; 36(9):755-759. PubMed ID: 32157927
[TBL] [Abstract][Full Text] [Related]
25. Weight loss significantly reduces serum lipocalin-2 levels in overweight and obese women with polycystic ovary syndrome.
Koiou E; Tziomalos K; Katsikis I; Kandaraki EA; Kalaitzakis E; Delkos D; Vosnakis C; Panidis D
Gynecol Endocrinol; 2012 Jan; 28(1):20-4. PubMed ID: 21756081
[TBL] [Abstract][Full Text] [Related]
26. Ovulation induction in polycystic ovary syndrome.
Vause TDR; Cheung AP;
J Obstet Gynaecol Can; 2010 May; 32(5):495-502. PubMed ID: 20500959
[TBL] [Abstract][Full Text] [Related]
27. A brief update on the evidence supporting the treatment of infertility in polycystic ovary syndrome.
Costello MF; Misso ML; Balen A; Boyle J; Devoto L; Garad RM; Hart R; Johnson L; Jordan C; Legro RS; Norman RJ; Moran L; Mocanu E; Qiao J; Rodgers RJ; Rombauts L; Tassone EC; Thangaratinam S; Vanky E; Teede HJ
Aust N Z J Obstet Gynaecol; 2019 Dec; 59(6):867-873. PubMed ID: 31514246
[TBL] [Abstract][Full Text] [Related]
28. Exploring factors related to changes in body composition, insulin sensitivity and aerobic capacity in response to a 12-week exercise intervention in overweight and obese women with and without polycystic ovary syndrome.
Scott D; Harrison CL; Hutchison S; de Courten B; Stepto NK
PLoS One; 2017; 12(8):e0182412. PubMed ID: 28771628
[TBL] [Abstract][Full Text] [Related]
29. Prospective evaluation of basal stromal Doppler studies in women with good ovarian reserve and infertility undergoing in vitro fertilization-embryo transfer treatment: patients with polycystic ovary syndrome versus ovulatory patients.
Younis JS; Jadaon JE; Haddad S; Izhaki I; Ben-Ami M
Fertil Steril; 2011 Apr; 95(5):1754-8. PubMed ID: 21300343
[TBL] [Abstract][Full Text] [Related]
30. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
[TBL] [Abstract][Full Text] [Related]
31. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
Ujvari D; Hulchiy M; Calaby A; Nybacka Å; Byström B; Hirschberg AL
Hum Reprod; 2014 Jul; 29(7):1526-35. PubMed ID: 24842895
[TBL] [Abstract][Full Text] [Related]
32. Life Modifications and PCOS: Old Story But New Tales.
Gu Y; Zhou G; Zhou F; Wu Q; Ma C; Zhang Y; Ding J; Hua K
Front Endocrinol (Lausanne); 2022; 13():808898. PubMed ID: 35498415
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of an Integrated Mobile Application for Lifestyle Modifications in Overweight Women with Polycystic Ovarian Syndrome: A Randomized Controlled Trial.
Lee H; Lee SH
Life (Basel); 2023 Jul; 13(7):. PubMed ID: 37511908
[TBL] [Abstract][Full Text] [Related]
34. The effect of mildly stimulated cycle versus artificial cycle on pregnancy outcomes in overweight/obese women with PCOS prior to frozen embryo transfer: a retrospective cohort study.
Guan L; Wu H; Wei C; Pang C; Liu D; Yu X; Xiang S; Lian F
BMC Pregnancy Childbirth; 2022 May; 22(1):394. PubMed ID: 35525951
[TBL] [Abstract][Full Text] [Related]
35. [Polycystic ovary syndrome does not affect blastulation nor cumulative live birth rates].
Delaroche L; Dupont C; Oger P; Aubriot FX; Lamazou F; Yazbeck C
Gynecol Obstet Fertil Senol; 2019 Sep; 47(9):655-661. PubMed ID: 31336185
[TBL] [Abstract][Full Text] [Related]
36. Overweight and high serum total cholesterol were risk factors for the outcome of IVF/ICSI cycles in PCOS patients and a PCOS-specific predictive model of live birth rate was established.
Gao L; Li M; Wang Y; Zeng Z; Xie Y; Liu G; Li J; Zhang B; Liang X; Wei L; Yang X
J Endocrinol Invest; 2020 Sep; 43(9):1221-1228. PubMed ID: 32221909
[TBL] [Abstract][Full Text] [Related]
37. [Clinical application of in vitro maturation of human immature oocytes for infertile women with polycystic ovary syndrome].
Xu YP; Xiang HF; Zou WW; Li ZL; Zhang ZG; Zhou P; Cao YX
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):14-8. PubMed ID: 22455687
[TBL] [Abstract][Full Text] [Related]
38. Effect of body mass index on pregnancy outcomes with the freeze-all strategy in women with polycystic ovarian syndrome.
Qiu M; Tao Y; Kuang Y; Wang Y
Fertil Steril; 2019 Dec; 112(6):1172-1179. PubMed ID: 31843094
[TBL] [Abstract][Full Text] [Related]
39. The Nutritional Intervention Improves the Metabolic Profile of Overweight and Obese PCOS Along with the Differences in Gut Microbiota.
Fu L; Li Y; Bian Y; Wang Q; Li J; Wang Y; Zhang T; Zou X; Cui L; Chen Z
Reprod Sci; 2023 Jul; 30(7):2210-2218. PubMed ID: 36656424
[TBL] [Abstract][Full Text] [Related]
40. Effect of body mass index on in vitro fertilization outcomes in women with polycystic ovary syndrome.
Bailey AP; Hawkins LK; Missmer SA; Correia KF; Yanushpolsky EH
Am J Obstet Gynecol; 2014 Aug; 211(2):163.e1-6. PubMed ID: 24657792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
